03-Jun-2009
TECOS (Trial Evaluating Cardiovascular Outcomes with Sitagliptin) has been recruiting patients in the United States since December 2008 and with nearly 100 patients already randomised, TECOS is now about to begin recruitment across a number of countries around the world.
Since early 2009 the Duke Clinical Research Institute (DCRI) and the Diabetes Trials Unit, University of Oxford (DTU) have hosted a number of training days (Investigator Meetings) for new clinical sites in North America, India and Europe, and will be launching the trial in the Asia/Pacific regions over the Summer. These Investigator Meetings provide the doctors and nurses at each hospital or primary care practice taking part in TECOS the opportunity to meet other researchers and to share their ideas and experience as well as allowing the academic leadership for TECOS to deliver specific training related to the TECOS trial. This usually includes a review of the protocol, advice for performing the trial to an internationally accepted high scientific standard (ICH-GCP) and discussion of clinical issues that are relevant to TECOS such as the importance of regular health monitoring to guide treatment options.